Targovax reports interim tumor response data from phase I study of ONCOS-102 in advanced melanoma Sep. 27, 2018
Concert Pharmaceuticals amends protocol of phase IIa trial with CTP-543 in alopecia areata Sep. 27, 2018
Patient recruitment starts in phase III study of Ameluz plus BF-RhodoLED in superficial BCC Sep. 27, 2018
RSS